Kimelman & Baird’s AbbVie ABBV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$5.77M	Hold	31,070	–	–	0.47%	39
2025 Q1	$6.51M	Hold	31,070	–	–	0.55%	34
2024 Q4	$5.52M	Sell	31,070 -2,696	-8%	-$479K	0.44%	40
2024 Q3	$6.67M	Hold	33,766	–	–	0.53%	37
2024 Q2	$5.79M	Buy	+33,766	New	+$5.79M	0.48%	40
2021 Q2	$3.3M	Buy	+29,289	New	+$3.3M	0.29%	49
2019 Q3	$2.2M	Sell	29,014 -20	-0.1%	-$1.51K	0.3%	51
2019 Q2	$2.11M	Buy	29,034 +606	+2%	+$44.1K	0.29%	49
2019 Q1	$2.29M	Hold	28,428	–	–	0.33%	50
2018 Q4	$2.62M	Hold	28,428	–	–	0.41%	47
2018 Q3	$2.69M	Hold	28,428	–	–	0.34%	51
2018 Q2	$2.63M	Buy	+28,428	New	+$2.63M	0.35%	50
2017 Q4	$2.75M	Hold	28,400	–	–	0.39%	49
2017 Q3	$2.52M	Hold	28,400	–	–	0.38%	52
2017 Q2	$2.06M	Sell	28,400 -100	-0.4%	-$7.25K	0.31%	56
2017 Q1	$1.86M	Hold	28,500	–	–	0.28%	53
2016 Q4	$1.79M	Hold	28,500	–	–	0.3%	50
2016 Q3	$1.8M	Hold	28,500	–	–	0.32%	50
2016 Q2	$1.76M	Hold	28,500	–	–	0.32%	51
2016 Q1	$1.63M	Hold	28,500	–	–	0.3%	52
2015 Q4	$1.69M	Buy	+28,500	New	+$1.69M	0.32%	56
2015 Q2	$1.92M	Sell	28,500 -1,902	-6%	-$128K	0.33%	59
2015 Q1	$1.78M	Hold	30,402	–	–	0.32%	59
2014 Q4	$1.99M	Buy	30,402 +302	+1%	+$19.8K	0.36%	56
2014 Q3	$1.74M	Hold	30,100	–	–	0.33%	61
2014 Q2	$1.7M	Hold	30,100	–	–	0.3%	63
2014 Q1	$1.55M	Hold	30,100	–	–	0.29%	58
2013 Q4	$1.59M	Buy	30,100 +1,600	+6%	+$84.5K	0.3%	60
2013 Q3	$1.28M	Hold	28,500	–	–	0.25%	64
2013 Q2	$1.18M	Buy	+28,500	New	+$1.18M	0.25%	64